We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GNLX market cap is 97.25M. The company's latest EPS is USD -1.0591 and P/E is -3.44.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Revenue | 68k | 170k | 0 | 0 | 0 |
Operating Income | -3.09M | -6.46M | -5.4M | -5.31M | -7M |
Net Income | -3.5M | -10.36M | -5.82M | -5.35M | -6.77M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 11.07M | 170k |
Operating Income | -14.61M | -3.01M | -24.17M |
Net Income | -16.38M | -5.21M | -28.3M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Assets | 5.53M | 14.62M | 31.36M | 34.07M | 27.89M |
Total Liabilities | 41.31M | 11.93M | 9.11M | 10.04M | 8.42M |
Total Equity | -35.78M | 2.69M | 22.26M | 24.03M | 19.47M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 8.13M | 5.53M | 27.89M |
Total Liabilities | 41.24M | 41.31M | 8.42M |
Total Equity | -33.11M | -35.78M | 19.47M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Operating | -3.57M | -4.59M | -10.01M | -13.37M | -20.28M |
Investing | -49k | -109k | -505k | -782k | -14.72M |
Financing | -478k | 14.64M | 37.26M | 43.62M | 44.02M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -6.59M | -3.57M | -20.28M |
Investing | N/A | -49k | -14.72M |
Financing | -270k | -478k | 44.02M |
Market Cap | 97.25M |
Price to Earnings Ratio | -3.44 |
Price to Sales Ratio | 568.75 |
Price to Cash Ratio | 10.33 |
Price to Book Ratio | 4.99 |
Dividend Yield | - |
Shares Outstanding | 26.72M |
Average Volume (1 week) | 112.92k |
Average Volume (1 Month) | 127.92k |
52 Week Change | -84.18% |
52 Week High | 40.98 |
52 Week Low | 3.06 |
Spread (Intraday) | 0.09 (2.44%) |
Company Name | Genelux Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.genelux.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions